Original Article

A 30-Month Experience of Thoracic Empyema in a Tertiary Hospital: Emphasis on Differing Bacteriology and Outcome Between the Medical Intensive Care Unit (MICU) and Medical Ward

Authors: Yu-Chao Lin, MD, Hung-Jen Chen, MD, Yi-Heng Liu, MD, Chuen-Ming, Shih MD, Wu-Huei Hsu, MD, Chih-Yen Tu, MD

Abstract

Objectives: To analyze the causative pathogens and outcomes of patients with thoracic empyema admitted to the medical intensive care unit (MICU) and medical ward.


Methods: We prospectively studied the empyemic patients in the MICU and retrospectively analyzed the medical records of empyemic patients in the medical ward treated in a tertiary university hospital from April 2001 to September 2003.


Results: During this period, 116 patients in the medical ward and 78 patients in MICU had complicated parapneumonic effusions or empyemas. Effusion cultures were positive in 164 patients (85%); a total of 147 and 78 microorganisms were isolated from the 106 medical ward patients and 58 MICU patients, respectively. No matter whether medical ward or MICU patients, aerobic Gram-negative organisms were the most common bacteria in positive-culture effusions (110, 67%). Klebsiella pneumoniae (14, 24%) was the predominant pathogen among the MICU patients, and Streptococcus spp. (28, 26%) was the main pathogen among the medical ward patients. Compared with these positive-culture empyemic patients in the medical ward, MICU patients had a significantly higher percentage of aerobic Gram-negative organism infections (P = 0.034) and a higher infection-related mortality rate (P = 0.01).


Conclusion: The mortality and predominant pathogens in patients with complicated parapneumonic effusions or thoracic empyemas in the medical ward and MICU were different. The increasing Gram-negative pathogens in empyemas have become an urgent problem.


Key Points


* Different bacteriologies between the medical ward and medical intensive care unit determine empirical antibiotic use and might lead to different clinical outcomes.


* Streptococcus spp. was the most commonly isolated pathogen in the medical ward, and K pneumoniae was the most frequently isolated pathogen in the medical intensive care unit group.


* The markedly high rate of aerobic Gram-negative bacterial infection in the two groups might be associated with the high incidence of underlying diseases (86%), especially in the relatively immunocompromised hosts with diabetes mellitus and malignancy.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Fry AM, Shay DK, Holman RC, et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988–2002. JAMA 2005;294:2712–2719.
 
2. Alfageme I, Munoz F, Pena N, et al. Empyema of the thorax in adults, etiology, microbiologic findings, and management. Chest 1993;103:839–843.
 
3. Finland M, Barnes MW. Changing ecology of acute bacterial empyema: occurrence and mortality at Boston City Hospital during 12 selected years from 1935 to 1972. J Infect Dis 1978;274–291.
 
4. Mansharamani NG, Koziei H. Chronic lung sepsis: lung abscess, bronchiectasis, and empyema. Curr Opin Pulm Med 2003;9:181–185.
 
5. Ruiz M, Ewig S, Marcos MA, et al. etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999;160:397–405.
 
6. Renner H, Gabor S, Pinter H, et al. Is aggressive surgery in pleural empyema justified? Eur J Cardiothorac Surg 1998;117–122.
 
7. Smith JA, Mullerworth MH, Westlake GW, et al. Empyema thoracis: a 14-year experience in a teaching center. Ann Thorac Surg 1991;51:39–42.
 
8. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema: a retrospective review in two military hospitals. Chest 1993;103:1502–1507.
 
9. Vianna NJ. Nontuberculous bacterial empyema in patients with and without underlying disease. JAMA 1971;215:69–75.
 
10. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146–155.
 
11. Leibovici L, Shraga I, Drucker M, et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379–386.
 
12. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462–474.